Literature DB >> 24170207

Serum pepsinogen reference intervals in apparently healthy Chinese population with latex enhanced turbidimetric immunoassay.

Meng Huang1, Ai-Guo Tang, Sa Mu, Jing-Jing Yang, Zhong-Yuan Xiang, Bo Liu, Jia-Jin Yang.   

Abstract

AIM: Serum pepsinogen (sPG) has been used to help in diagnosing atrophic corpus gastritis and in screening for gastric cancer non-invasively. There are as yet no reports on sPG reference intervals (RIs) with latex enhanced turbidimetric immunoassay (LIA). In this study, we established the RIs for sPG in a healthy Chinese population using LIA.
METHODS: Serum PGI and PGII levels in a healthy population (aged 17-80 years) were measured simultaneously using LIA. RIs were determined following Clinical Laboratory and Standards Institute C28-A3 guidelines using a non-parametric method.
RESULTS: 95% RIs in men (ng/mL) were: ≤40 years old, 25.53-100.76 for PGI and ≤24.42 for PGII; 41-50 years old, 26.62-124.74 for PGI and ≤26.81 for PGII; and 51-80 years old, 30.40-153.25 for PGI and ≤32.62 for PGII. Corresponding RIs for women (ng/mL) were: ≤40 years old, 21.20-87.44 for PGI and ≤25.53 for PGII; and 41-80 years, 26.40-127.46 for PGI and ≤30.18 for PGII. 95% RI for PGI/PGII in both men and women at any age was ≥2.51.
CONCLUSIONS: We established the RIs for sPG using LIA in a healthy Chinese population, which can provide a reference for clinical and laboratory studies.

Entities:  

Keywords:  GASTRIC CANCER; GASTRITIS; LABORATORY TESTS; diagnostic screening

Mesh:

Substances:

Year:  2013        PMID: 24170207     DOI: 10.1136/jclinpath-2013-201942

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  2 in total

1.  Preliminary Study on Reference Interval of Serum Pepsinogen in Healthy Subjects.

Authors:  Liang Zhang; Ye Niu; Yin-Jiang Lv; Li-Feng Wu; Qi-Lei Hu; Rong Huang; Ru-Jin Xu
Journal:  Patient Prefer Adherence       Date:  2021-12-09       Impact factor: 2.711

Review 2.  Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.

Authors:  Ya-kai Huang; Jian-chun Yu; Wei-ming Kang; Zhi-qiang Ma; Xin Ye; Shu-bo Tian; Chao Yan
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.